| 1995 |
Synaptotagmin VI (Syt6) shares the common synaptotagmin domain architecture (single transmembrane region + two C2 domains). The first C2 domain of Syt VI does NOT bind phospholipids in a Ca2+-dependent manner (unlike Syt I, II, III, V, VII). All Syt isoforms tested, including Syt VI, interact with clathrin-AP2 (Kd = 0.1–1.0 nM) and with neural and non-neural syntaxins via their cytoplasmic C2 domain region. |
In vitro binding assays, Ca2+-dependent phospholipid binding assays, clathrin-AP2 pull-down, syntaxin interaction assays |
Nature |
High |
7791877
|
| 1996 |
The C-terminus of Syt6 (synaptotagmin 6) interacts with neurexins in a calcium-independent manner, mediated by two mirror-image sequence motifs (Leu-X-His-Trp and Trp-His-X-Leu) in the C-terminal 34 amino acids. The same C-terminal domain also mediates calcium-dependent enrichment of calmodulin via the first of these motifs. Deletion or substitution of residues in these motifs greatly reduces neurexin binding. |
Affinity purification from solubilized brain membranes, recombinant protein binding assays, site-directed mutagenesis, 125I-calmodulin binding |
Biochemistry |
High |
8901523
|
| 1999 |
Synaptotagmin VI (along with Syt III, V, and X) forms beta-mercaptoethanol-sensitive homodimers and heterodimers via a conserved N-terminal cysteine motif (three cysteines at positions ~10, 21, and 33). Site-directed mutagenesis of the first cysteine residue abolishes stable homodimer formation of Syt VI and heterodimer formation between Syt VI and Syt III, V, or X. |
Co-immunoprecipitation, site-directed mutagenesis, reducing agent sensitivity assays |
The Journal of biological chemistry |
High |
10531343
|
| 2001 |
Synaptotagmin VI is localized to the outer acrosomal membrane of human sperm. A specific anti-Syt VI antibody and a recombinant GST fusion protein containing the C2A and C2B domains of Syt VI both abrogated calcium-triggered acrosomal exocytosis in permeabilized spermatozoa, demonstrating that Syt VI is required for this secretory process. Syt VI is also necessary for Rab3A-promoted acrosomal exocytosis at low calcium concentrations. Phorbol ester-dependent phosphorylation of the C2A–C2B fusion protein abolished its inhibitory effect on exocytosis. |
Western blot, immunocytochemistry (optical and electron microscopy), function-blocking antibody assays in permeabilized sperm, recombinant protein inhibition assays, in vitro phosphorylation |
Developmental biology |
High |
11437455
|
| 2001 |
Genomic analysis identified human homologues for all known rodent synaptotagmin genes, establishing the full genomic structure of the synaptotagmin family. Comparison of genomic structures clarified the phylogeny of different subgroups, including Syt6, and revealed alternative splicing possibilities. |
TBLASTn genomic database searches, comparative genomic structure analysis |
Genomics |
Low |
11543631
|
| 2005 |
Protein kinase C betaII (PKCbetaII) phosphorylates Syt VI at Thr418 and/or Thr419 in the polybasic region (KKKTTIK) of the C2B domain, and at Thr284 in the polybasic region (KCKLQTR) of the C2A domain. PKC-mediated phosphorylation of either C2 domain abolishes their inhibitory effect on acrosomal exocytosis in permeabilized spermatozoa. An antibody recognizing the phosphorylated C2B polybasic region detected endogenous phosphorylated Syt VI in the sperm acrosomal region, and immunolabeling decreased upon sperm stimulation, indicating dephosphorylation occurs during exocytosis. |
Site-directed mutagenesis, in vitro phosphorylation with purified PKCbetaII, function-blocking assays in permeabilized sperm, phospho-specific antibody immunolabeling |
Developmental biology |
High |
16111671
|
| 2010 |
Calcineurin (a calcium-dependent phosphatase) dephosphorylates Syt VI at the polybasic region of its C2B domain during the early stages of human sperm acrosomal exocytosis. This dephosphorylation is required for progression of exocytosis: calcineurin inhibition (cyclosporin A) blocked exocytosis, and an inhibitor-insensitive catalytically active calcineurin domain rescued it. Premature calcineurin-driven dephosphorylation before stimulation inhibited exocytosis, an effect rescued by a phosphomimetic Syt VI C2B-T418E/T419E mutant, demonstrating that temporally regulated dephosphorylation of Syt VI is essential. |
Calcineurin inhibitor (cyclosporin A) functional assays in permeabilized sperm, recombinant active calcineurin domain rescue, in vitro dephosphorylation of recombinant Syt VI C2B, phosphomimetic mutant rescue experiments |
The Journal of biological chemistry |
High |
20551332
|
| 2012 |
Following ischemic insult, the transcriptional repressor REST (RE-1 silencing transcription factor) binds the syt6 gene promoter among a subset of target genes in hippocampal neurons. REST assembles a repressor complex containing CoREST, mSin3A, histone deacetylases 1 and 2, G9a histone methyltransferase, and MeCP2 at the syt6 promoter, orchestrating epigenetic silencing and reducing Syt6 mRNA and protein levels. RNAi-mediated depletion of REST prevented these epigenetic modifications and restored syt6 expression. |
ChIP (chromatin immunoprecipitation), RNAi knockdown in vivo, mRNA/protein quantification, in vivo hippocampal injection of dominant-negative REST |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
22371606
|
| 2015 |
Among eight synaptotagmin isoforms examined, only Syt6 knockdown impaired activity-induced release of endocytosed (exogenous) BDNF-quantum dot conjugates from postsynaptic dendrites of cultured hippocampal neurons. Repetitive neuronal spiking triggered BDNF-QD release preferentially at postsynaptic sites in a glutamate receptor-dependent manner, and this required Syt6 (and complexin 1/2). In contrast, activity-induced release of endogenously synthesized BDNF did not depend on Syt6, indicating Syt6 specifically regulates exocytic release of endosomal (recycled) BDNF from dendrites. |
shRNA knockdown of individual Syt isoforms, quantum dot-tagged BDNF live imaging, activity-dependent secretion assays in cultured hippocampal neurons, glutamate receptor pharmacology |
Proceedings of the National Academy of Sciences of the United States of America |
High |
26216953
|
| 2021 |
Syt6-Cre transgenic mice express Cre recombinase (and thus mark Syt6-expressing cells) predominantly in layer 6 corticothalamic neurons (CTn) and to a lesser extent layer 5 CTn in prefrontal, motor, cingulate, and retrosplenial cortices. Cortical expression begins embryonically and reaches the adult pattern by postnatal day 15. Optogenetic stimulation of Syt6-Cre+ neurons in prefrontal cortex induced oscillatory local field potential activity resembling cortical downstates observed during slow-wave sleep or quiet waking. |
Cre-reporter lineage tracing, immunohistochemistry, axon varicosity quantification, in vivo optogenetic stimulation with local field potential recording |
The Journal of comparative neurology |
Medium |
34617601
|
| 2024 |
Quantitative proteomic analysis of MPTP-induced Parkinson's disease mouse brain identified Syt6 as a hub node protein associated with regulatory T-cell (Treg) networks and rTMS treatment response. Virus-mediated RNA interference of Syt6 in MPTP mice was used to validate its functional role: Syt6 knockdown affected the therapeutic outcomes of rTMS on motor function and Treg modulation. |
Quantitative proteomics (label-free), virus-mediated RNAi in vivo, motor behavior assessment, flow cytometry of Tregs |
Molecular neurodegeneration |
Low |
39456006
|